1、FAMILY PLANNING MARKET REPORTD E C E M B E R 201 9AC K N OW L E D G E M E N TS:This report was produced as part of the landmark FP2020 Global Markets Visibility Project that the Clinton Health Access Initiative,Inc.(CHAI)launched in early 2014 in conjunction with the Reproductive Health Supplies Coa
2、lition(RHSC).The shipment data provided by suppliers is the foundation of the reports analyses and allows CHAI to address information gaps and construct a comprehensive view of the reproductive health contraceptive product market.We would like to thank current participating suppliers:Bayer,CR Zizhu,
3、Cipla,Cupid,Female Health Company,Helm AG*,Incepta Pharmaceuticals,Merck(MSD),Mylan,Pfizer,Pregna,PT Tunggal,Shanghai Dahua,SMB,and Techno Drugs,as well as our partner,Concept Foundation,for their support in collecting and aggregating 2014-2017*data from the Generic Manufacturers for Reproductive He
4、alth(the GEMS Caucus).We are also grateful to our colleagues from the Coordinated Supply Planning Group(CSP),John Snow Inc.(JSI),United Nations Population Fund(UNFPA),the U.S.Department of International Development(USAID),the Global Health Supply-Chain Procurement and Supply-Management(GHSC-PSM),and
5、 FP2020,for their invaluable feedback during the development and refinement of various market analyses.*HELM AG was a participating supplier in the FP2020 Global Markets Visibility Project for the FP 2015,2016,and 2017 Market Reports.In September 2017,HELM AG sold its wholly-owned subsidiary company
6、,HELM Medical GmbH,to Sanavita Pharmaceuticals GmbH.Refer to page 18 for more information on HELM AG and other participating suppliers.*CHAI collected data directly from suppliers in the GEMs Caucus for the 2018 shipment data.SUPPLIER SHIPMENT ANALYSISDONOR SPEND ANALYSISFUTURE OUTLOOKDISCUSSION WIT